World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Uncategorized

M.D. Sass Brings High Conviction Value Strategy to ETF Market

Cision PR Newswire by Cision PR Newswire
March 4, 2026
in Uncategorized
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

The firm’s flagship Concentrated Value Strategy is being made available to all investors for the first time 

NEW YORK, March 4, 2026 /PRNewswire/ — M.D. Sass, the independent asset management firm founded and led by Martin D. Sass, today announced the launch of its first exchange-traded fund (ETF). M.D. Sass Concentrated Value (Ticker: SASS) will be managed by Ari Sass, President of the firm, and will mirror the Concentrated Value strategy he has managed for institutional clients since 2019. 

“An ETF launch continues the firm’s history of delivering innovative solutions for our clients for over 50 years,” said Martin D. Sass, Founder and CEO of M.D. Sass. “The liquid, transparent, and tax-efficient structure of an actively managed ETF enables us to bring our deeply researched and highest-conviction views to the investment marketplace at large.” 

“We believe the launch of SASS is especially timely today given the U.S. equity market’s heavy concentration in AI-infrastructure stocks, which provides insufficient diversification and risk management”, adds Ari Sass.

“Concentrated Value is a high conviction, opportunistic U.S. equity strategy focused on a  differentiated portfolio of 20-25 large and mid-cap stocks. We seek investment opportunities  where our outlook for earnings is materially above consensus and where we believe valuation  provides a compelling risk/reward,” says Ari. “Combined with a culture of intellectual honesty,  transparency and communication, we act decisively when new information may invalidate prior  beliefs.”

SASS will trade on the New York Stock Exchange and will launch with more than $70 million in  seed capital from existing clients and company principals. Marking M.D. Sass’ entry into the  ETF marketplace, this launch extends the firm’s long-standing expertise and approach to value  investing to the broadest range of investors.

About M.D. Sass:

M.D. Sass is an independent asset management firm that has been creating highly  differentiated investment strategies for over 50 years. We take pride in identifying undiscovered and misperceived opportunities through rigorous research. Today, the firm manages capital on  behalf of public funds, corporations, Taft-Hartley funds, endowments/foundations, private banks, registered investment advisors, OCIOs, and family offices.

Investors should consider the investment objectives, risks, and charges and expenses of the ETF carefully before investing. A prospectus, which contains this and other  information about the ETF, may be obtained by calling 1-800-617-0004 or by visiting  www.MDSassETF.com. The prospectus should be read carefully before investing. 

Investing involves risk. Principal loss is possible. The ETF is a newly organized, management  investment company with no operating history. In addition, there can be no assurance that the ETF will grow to, or maintain, an economically viable size, in which case the Board of the Trust  may determine to liquidate the ETF. Mid-cap companies may not have the management  experience, financial resources, product diversification and competitive strengths of large-cap  companies and, therefore, their securities tend to be more volatile than the securities of larger,  more established companies, making them less liquid than other securities. Value stocks may  perform differently from the market as a whole and an investment strategy purchasing these  securities may cause the ETF to at times underperform equity funds that use other investment  strategies. The ETF is non-diversified. Compared to other funds, the ETF may invest more of its assets in a smaller number of companies. Gains or losses on a single stock may have greater  impact on the ETF.

If the ETF focuses its investments in the securities of a particular issuer or companies in a  particular country, group of countries, region, market, industry, group of industries, sector or  asset class, the ETF’s exposure to various risks will be heightened, including price volatility and  adverse economic, market, political or regulatory occurrences affecting that issuer, country,  group of countries region, market, industry, group of industries, sector or asset class. The ETF  will seek to benefit from special situations, such as mergers, reorganizations, or other unusual  events expected to affect a particular issuer.

Exchange-traded funds are subject to additional risks that do not apply to conventional mutual  funds, including the risks that the market price of an exchange-traded fund’s shares may trade  at a premium or discount to its net asset value, an active secondary trading market may not  develop or be maintained, or trading may be halted by the exchange in which they trade, which  may impact an exchange-traded fund’s ability to sell its shares. Shares of any exchange-traded  fund are bought and sold at market price (not net asset value) and are not individually  redeemed from the exchange-traded fund. Brokerage commissions will reduce returns.
The M.D. Sass Concentrated Value ETF is distributed by Quasar Distributors, LLC

Cision View original content:https://www.prnewswire.com/news-releases/md-sass-brings-high-conviction-value-strategy-to-etf-market-302703791.html

SOURCE M.D. Sass

Cision PR Newswire

Cision PR Newswire

Related Posts

love around the world cultures

Love Around the World: How Different Cultures Define Romance

March 17, 2026
Oscars 2026 fashion

The Best Oscars 2026 Red Carpet Fashion Moments That Defined the Night

March 16, 2026
eating disorders

Eating Disorders in Women: What Is Really Going On and Where to Get Help

March 16, 2026
Mels Robins skin care

The Dermatologist Skincare Routine That Actually Works

March 16, 2026

Ulike Spring: Dare to Glow — Celebrating Confident and Aspirational Women

March 9, 2026

Wilentz, Goldman & Spitzer, P.A. Welcomes Former Presiding Judge Robert J. Mega to the Firm

March 9, 2026

Popular News

  • Dreame will unveil its latest wet dry vacuum innovations in Silicon Valley, building on rapid growth across the world

    0 shares
    Share 0 Tweet 0
  • IFS announces filing of 2025 Annual Report on Form 20-F

    0 shares
    Share 0 Tweet 0
  • Related Digital Announces Financing for $16 Billion Oracle Data Center Project in Saline Township, Michigan

    0 shares
    Share 0 Tweet 0
  • Restaurant Management Company of Wichita Data Breach Alert Issued By Wolf Haldenstein

    0 shares
    Share 0 Tweet 0
  • New Survey: 1 in 3 Americans Say AI Diagnosed a Health Problem Their Doctor Missed

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler